AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11736878
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B (AmB) administered at 1 mg kg(‐1) day(‐1) in lipid emulsion (doseform=2)
Trial: 31972580
Drug: Compression therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compression therapy (71% of patients received this intervention)
Trial: 16670692
Drug: Imedeen Prime
RxNorm normalized name: epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Imedeen Prime Renewal (two tablets twice daily for 6 months)
Trial: 3597568
Drug: Family therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family therapy intervention (approximately six sessions within 3-5 months of bereavement)
Trial: 8712425
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) bolus injection of meperidine 0.6 mg/kg and ketorolac 0.5 mg/kg
Trial: 19164205
Drug: Erlotinib 150
RxNorm normalized name: erlotinib 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib 150 mg
Trial: 9537487
Drug: Separate injection
RxNorm normalized name: Atractylis separate root
DrugBank: Atractylodes lancea root (DB14693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate injection of DTaP and candidate Hib vaccine
Trial: 7012968
Drug: Intermittent tetracycline
RxNorm normalized name: Tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent tetracycline therapy
Trial: 21368772
Drug: Anthrax Vaccine
RxNorm normalized name: ANTHRAX VACCINE
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthrax Vaccine Adsorbed (AVA)
Trial: 30628950
Drug: Hydrocortisone continuous
RxNorm normalized name: HYDROCORTISONE 10 mg in 1 g TOPICAL AEROSOL, SPRAY [Hydrocortisone Continuous]
DrugBank: Hydrocortisone (DB00741)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone continuous infusion (200 mg/d)
Trial: 9756554
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 6 g daily for 3 days
Trial: 22894911
Drug: Rapeseed oil
RxNorm normalized name: Rapeseed oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapeseed oil diet enriched with α-linolenic acid (ALA) (3.5 g/d)
Trial: 2060564
Drug: Caffeine 12
RxNorm normalized name: caffeine 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 12 mg.kg‐1.day‐1
Trial: 27180442
Drug: Topical cream
RxNorm normalized name: Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cream loaded with 2% Ananas comosus extract
Trial: 12476540
Drug: Flunisolide HFA
RxNorm normalized name: Flunisolide
DrugBank: Flunisolide acetate (DB14662)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flunisolide HFA (all doses)
Trial: 8169675
Drug: Intravenous slow
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous slow infusion of indomethacin
Trial: 29120039
Drug: Prostin 15M
RxNorm normalized name: Prostin VR
DrugBank: Carboprost tromethamine (DB00429)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostin 15M 250 microg intramuscular injection every two hours until 1 cm cervical dilation, then every three hours until abortion.
Trial: 16234005
Drug: Wireless capsule
RxNorm normalized name: careless weed pollen extract
DrugBank: Amaranthus palmeri pollen (DB10459)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wireless capsule endoscopy (WCE)
Trial: 28085022
Drug: Whole-grain (WG)
RxNorm normalized name: rice (whole grain) allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-grain (WG) foods (80 g/day)
Trial: 25752438
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg VIA-2291 for 24 weeks
Trial: 2575521
Drug: Propranolol 40
RxNorm normalized name: propranolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 40 mg (P40)
Trial: 27496798
Drug: Steroid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid treatment
Trial: 8233289
Drug: IVIG treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG treatment
Trial: 29093246
Drug: Lumbrokinase in
RxNorm normalized name: lumbrokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lumbrokinase in combination with low molecular heparin and sequential warfarin (n=30)
Trial: 21670447
Drug: Palifermin 120
RxNorm normalized name: palifermin
DrugBank: Palifermin (DB00039)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Palifermin 120 μg/kg
Trial: 16478746
Drug: Weekly darbepoetin
RxNorm normalized name: Darbepoetin Alfa
DrugBank: Darbepoetin alfa (DB00012)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly darbepoetin alfa
Trial: 2946313
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of fentanyl
Trial: 2946313
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of alfentanil
Trial: 10830451
Drug: Hypo-osmolar ORS
RxNorm normalized name: Orserdu
DrugBank: Elacestrant (DB06374)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypo-osmolar ORS (224 mmol/L)
Trial: 18466210
Drug: Insulin pump
RxNorm normalized name: insulin pump syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin pump treatment
Trial: 12830340
Drug: Benazepril 10
RxNorm normalized name: benazepril 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benazepril 10 mg o.d.
Trial: 30874716
Drug: Drug therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug therapy (n=1096)
Trial: 29953782
Drug: Intraperitoneal combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal combined with intravenous neoadjuvant chemotherapy
Trial: 26035186
Drug: Vortioxetine 15
RxNorm normalized name: vortioxetine 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vortioxetine 15 mg
Trial: 21606533
Drug: Patients carrying
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients carrying CC(rs12979860)
Trial: 12192323
Drug: Specialized amino
RxNorm normalized name: silk amino acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specialized amino acid mixture (14 g arginine, 3 g HMB, 14 g glutamine)
Trial: 820365
Drug: Podophyllin treatment
RxNorm normalized name: podophyllin
DrugBank: Podophyllin (DB09094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Podophyllin treatment for simple plantar warts
Trial: 16543072
Drug: Filgrastim 5
RxNorm normalized name: Filgrastim
DrugBank: Filgrastim (DB00099)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Filgrastim 5 microg/kg daily starting on day 1 posttransplant
Trial: 1604908
Drug: Sodium monofluorophosphate
RxNorm normalized name: Sodium Monofluorophosphate
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium monofluorophosphate (MFP) tablets for 7 days
Trial: 14759641
Drug: Amantadine 100
RxNorm normalized name: amantadine 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amantadine 100 mg twice daily
Trial: 8546884
Drug: Hyperhydrated subjects
RxNorm normalized name: Ex vivo, lentiviral vector (LV)-mediated, genetically modified autologous cell therapy intended for the stable provision of functional human iduronate-2-sulfatase (IDS) enzyme to subjects with Hunter syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperhydrated subjects (0.1 g sodium chloride (NaCl)/kg body wt and 26 mL water/kg body wt)
Trial: 25246664
Drug: Low-dose mannitol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose mannitol control
Trial: 22818224
Drug: Intravenous omeprazole
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous omeprazole 1mg/kg every 12 hours
Trial: 19880686
Drug: Armodafinil, 150
RxNorm normalized name: Armodafinil, 150 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Armodafinil, 150 mg
Trial: 25774646
Drug: Postcard intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postcard intervention (9 postcards over 12 months plus usual treatment)
Trial: 21120518
Drug: Caffeine (CAF)
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine (CAF) 3 mg kg(‐1)
Trial: 15000637
Drug: Saturated potassium
RxNorm normalized name: Potassium
DrugBank: Potassium (DB14500)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saturated potassium nitrate/dimethyl isosorbide in aqueous hydroxyethyl cellulose gel
Trial: 11723147
Drug: Low-carbohydrate meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-carbohydrate meal (25 g)
Trial: 25987072
Drug: 0.9% sodium
RxNorm normalized name: LMD with 0.9% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% sodium chloride injection before anesthesia induction (Control Group)
Trial: 29659672
Drug: ADI-PEG 20
RxNorm normalized name: ADI-PEG 20
DrugBank: Pegargiminase (DB06592)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ADI-PEG 20 18 mg/m2
Trial: 15967567
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg propiverine twice daily
Trial: 15967567
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg tolterodine twice daily
Trial: 10386467
Drug: Intramuscular injections
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injections of 240 mg polyestradiol phosphate (PEP) every second week for the first 8 weeks, followed by a maintenance dose of 240 mg every month
Trial: 19506392
Drug: GH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH treatment (1.3, 2.0, and 2.7 mg/m(2)/day)
Trial: 15730347
Drug: Nefazodone 200
RxNorm normalized name: NEFAZODONE 200MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nefazodone 200 mg twice daily (n = 34)
Trial: 14607207
Drug: Candesartan cilexetil,
RxNorm normalized name: Candesartan Cilexetil, 4 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan cilexetil, 8 mg once daily
Trial: 1873204
Drug: Oral therapy
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral therapy (8-methoxypsoralen)
Trial: 15741723
Drug: Sucrose solution
RxNorm normalized name: TootSweet 24% Oral Sucrose Solution
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucrose solution
Trial: 28315479
Drug: personalized pharmaceutical
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: personalized pharmaceutical and psychological education
Trial: 20704667
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) with parameters: wavelength 905 nm, frequency 5,000 Hz, power density of 12 mW/cm², dose of 2 J/cm², treatment time 120 seconds, total dose 12 J/cm²
Trial: 15565373
Drug: Glibenclamide +
RxNorm normalized name: glibenclamide
DrugBank: Glyburide (DB01016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glibenclamide + Metformin
Trial: 22832261
Drug: Intradermal low-antigen-content
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal low-antigen-content split inactivated vaccine
Trial: 19582577
Drug: Patient self-administered
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient self-administered abdominal pressure
Trial: 7649582
Drug: Human amylin
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human amylin infusion
Trial: 8988940
Drug: Dietary cholesterol
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary cholesterol intake (492 mg/d)
Trial: 27941394
Drug: Zidovudine (ZDV)
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine (ZDV) 300 mg b.i.d.
Trial: 2904474
Drug: acetazolamide 750
RxNorm normalized name: Acetazolamide
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: acetazolamide 750 mg per os
Trial: 18494791
Drug: 50 mg/day
RxNorm normalized name: infigratinib phosphate 50 mg/day (25 mg x 2) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg/day TPM
Trial: 12353197
Drug: Valacyclovir 500
RxNorm normalized name: valacyclovir 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valacyclovir 500 mg (13.9‐27.0 mg/kg) twice daily
Trial: 26432182
Drug: 675 mg
RxNorm normalized name: arginine 675 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 675 mg TEV-48125
Trial: 21672926
Drug: One extra
RxNorm normalized name: Acid Gone Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One extra daily injection of rLH
Trial: 8695243
Drug: Serum beta
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum beta HCG > or = 4 IU/l (multivariate analysis)
Trial: 23441598
Drug: Sevoflurane combined
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevoflurane combined with propofol and 8 mg of ondansetron
Trial: 23441598
Drug: Sevoflurane and
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevoflurane and 8 mg of ondansetron
Trial: 23441598
Drug: Propofol and
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol and 8 mg of ondansetron
Trial: 2966193
Drug: Low-dose adrenaline
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose adrenaline infusion
Trial: 22828645
Drug: MenC-TT booster
RxNorm normalized name: TT 173
DrugBank: TT 173 (DB17717)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MenC-TT booster dose
Trial: 12900588
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg (up-titrated to 100 mg if needed)
Trial: 9888118
Drug: Weekly contingent
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly contingent condition
Trial: 2006660
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment with a combination of triamterene and hydrochlorothiazide
Trial: 8934993
Drug: Combination IAN
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination IAN block and mock PDL injections (needle penetration only)
Trial: 22805174
Drug: Continuous Treatment
RxNorm normalized name: Continuously Clear
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous Treatment (CT)
Trial: 29328639
Drug: Hyaluronic acid
RxNorm normalized name: hyaluronic acid
DrugBank: Hyaluronic acid (non-animal stabilized) (DB19175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyaluronic acid (0.2 mL of 0.8% gel)
Trial: 10450387
Drug: One-step hydrogen
RxNorm normalized name: PostDay One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One-step hydrogen peroxide and multipurpose solutions
Trial: 24672936
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received inotropic agents, preload and afterload reducing therapy, anti-infection, etc.
Trial: 2979673
Drug: Pirenzepine 150
RxNorm normalized name: pirenzepine
DrugBank: Pirenzepine (DB00670)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine 150 mg
Trial: 6829485
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg Zn daily supplement (group B)
Trial: 11340315
Drug: Foot Reflex
RxNorm normalized name: Cuscuta reflexa extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Foot Reflex Zone Massage (FRZM) therapy
Trial: 26704611
Drug: Suppressive acyclovir
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Suppressive acyclovir therapy
Trial: 2360135
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (Cefotetan 0.5 g, Cefotetan 1.0 g, Ceftriaxone 0.25 g)
Trial: 695661
Drug: Prophylactic gestagen
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic gestagen therapy
Trial: 695661
Drug: Prophylactic gestagen
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic gestagen therapy initiated at the first missed period or later
Trial: 15049437
Drug: Augmentan film-coated
RxNorm normalized name: clavulanate
DrugBank: Clavulanic acid (DB00766)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Augmentan film-coated tablet (875/125)
Trial: 21862415
Drug: Eribulin mesylate
RxNorm normalized name: Eribulin Mesylate
DrugBank: Eribulin (DB08871)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Eribulin mesylate (1.4 mg/m²) administered as a 2- to 5-minute intravenous infusion on days 1, 8, and 15 of a 28-day cycle.
Trial: 24148807
Drug: Active conservative
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active conservative treatment (pelvic floor muscle training and bladder training)
Trial: 22362830
Drug: Brief Mobile
RxNorm normalized name: Chamaemelum nobile extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief Mobile Treatment (BMT)
Trial: 9822507
Drug: Intramuscular dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular dexamethasone (6 mg every 12 hours for a total of 4 doses)
Trial: 8126916
Drug: Intra-arterial infusions
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial infusions of epirubicin (Group B)
Trial: 30365356
Drug: Low-dose iron
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose iron sucrose (0 to 400 mg monthly)
Trial: 1290178
Drug: A/S 3
RxNorm normalized name: Amoxicillin/Sulbactam 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A/S 3 x 3 g for 3 days (Part II)
Trial: 11934682
Drug: Low-dose IGF-I
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose IGF-I therapy (40 microg.kg(‐1).day(‐1))
Trial: 19487635
Drug: Subcutaneous insulin
RxNorm normalized name: subcutaneous insulin pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous insulin infusion at 2.0 units/h
Trial: 31525168
Drug: Protein Supplementation
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein Supplementation (PRO; 28.7 g casein protein)
Trial: 17646509
Drug: Dexamethasone 16
RxNorm normalized name: dexamethasone 16 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 16 mg IV
Trial: 21384392
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser treatments on one side of the body three times per week for 2 weeks
Trial: 27503012
Drug: Telmisartan combined
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telmisartan combined with clopidogrel (50 mg/d)
Trial: 7248480
Drug: Free combination
RxNorm normalized name: SUNSCREEN-29 PABA-FREE COMBINATION LOT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free combination of 80 mg propranolol twice daily and 2.5 mg bendrofluazide twice daily
Trial: 7248480
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination (Inderetic) of 80 mg propranolol twice daily and 2.5 mg bendrofluazide twice daily
Trial: 21054769
Drug: 10/25 mg
RxNorm normalized name: Vaseretic 10/25 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10/25 mg amlodipine/HCTZ
Trial: 8529777
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg d-alpha-tocopheryl acetate daily
Trial: 8529777
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg d-alpha-tocopheryl acetate daily
Trial: 15836974
Drug: Iyengar yoga
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iyengar yoga therapy
Trial: 8172436
Drug: Low-dose radiation
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose radiation (2000 cGy to lymph node areas and 1000 to 1500 cGy to other involved organ sites)